研究進程

• Mode of Action

  Preclinical

  Phase I

  Phase II

  Phase III

  NDA

• AC-203 Epidermolysis Bullosa Simplex

  Preclinical

  Phase I

  Phase II

  Phase III

  NDA

• Mode of Action

  Preclinical

  Phase I

  Phase II

  Phase III

  NDA

• AC-1101 Granuloma Annulare

  Preclinical

  Phase I

  Phase II

  Phase III

  NDA

• AC-1101 Atopic Dermatitis

  Preclinical

  Phase I

  Phase II

  Phase III

  NDA